Home » Topics » Regulatory

Regulatory
RSS

RPR's Tilade approved for pediatric use

April 8, 1997

Human skin equivalent approved in Canada

April 8, 1997

Clinical efficacy and safety of Aphthasol reviewed

April 7, 1997

Court rules in favor of Novopharm regarding generic ranitidine product

April 7, 1997

FDA clears Faulding's generic captopril

April 7, 1997

Shire's sustained-release carbamazepine deemed approvable by FDA

April 4, 1997

Budesonide cleared in Canada for Crohn's disease

April 4, 1997

Digital Gene Technologies and Recordati collaborate on atherosclerosis research

April 4, 1997

New indication for liquid Nutropin approved by FDA

April 4, 1997

New epilepsy option approved in the U.S.

April 2, 1997

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....